Biopharma, Performance Materials and Life Science Segments of Merck Limited

Merck Limited's Biopharma, Performance Materials, and Life Science segments currently do not report specific carbon emissions data, as no emissions figures are available. The organisation is a merged entity, inheriting its climate commitments and targets from its parent company, Merck KGaA, at a cascade level of 3.

While specific reduction targets or achievements are not detailed, Merck KGaA has established science-based targets (SBTi) and participates in the Carbon Disclosure Project (CDP), indicating a commitment to transparency and accountability in climate action. These initiatives reflect a broader industry trend towards reducing greenhouse gas emissions and enhancing sustainability practices.

As a merged entity, Merck Limited's performance data may also be influenced by EMD Millipore Corporation, which operates at a cascade level of 2. However, without specific emissions data or reduction targets, the focus remains on the overarching commitments inherited from its parent organisation.

In summary, while detailed emissions data is currently unavailable, Merck Limited's segments are aligned with the climate initiatives of Merck KGaA, demonstrating a commitment to addressing climate change through inherited strategies and industry standards.